CSBR:NASDAQ
Champions Oncology Inc
US$4.77
arrow_upward
+0.42%(+0.020) 1D
ኖቬም 11, 11:18:31 ጥዋት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4.79
High
US$4.79
Low
US$4.77
Mkt. cap
66.39 ሚ
Avg. vol.
8.97 ሺ
Volume
2.80 ሺ
52-wk high
US$8.31
52-wk low
US$4.63
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Open
US$4.79
High
US$4.79
Low
US$4.77
Mkt. cap
66.39 ሚ
Avg. vol.
8.97 ሺ
Volume
2.80 ሺ
52-wk high
US$8.31
52-wk low
US$4.63
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
Central Oregon Daily
·
ከ46 ደቂቃዎች በፊት
S&P 500, Nasdaq rise over 1% as CoreWeave results calm AI spending jitters
The Globe and Mail
·
ከ25 ደቂቃዎች በፊት
3 Unstoppable Nasdaq-100 Stocks to Buy in November
The Motley Fool
·
ከ56 ደቂቃዎች በፊት
Okta’s Real Opportunity Isn’t Its S&P 500 Spot. It’s AI Agents.
Reuters
·
ከ6 ሰዓቶች በፊት
Mapping the Market: S&P 500 at risk of further losses
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com